• About Us
    • Contact Us
    • Login
    • ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
About Us Contact Us Login ObGFirst
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • COVID-19
Grand Rounds

Meta-Analysis: Umbilical Cord Clamping Method and Associated Outcomes after 34 Weeks

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Gomersall et al. (Pediatrics, 2020) performed a systematic review and meta-analysis to assess effects of umbilical cord clamping timing and cord milking in infants ≥ 34 weeks’ gestational age

METHODS:

  • Systematic review and meta-analysis
  • Data sources
    • Literature and trial registries through July 2019
  • Inclusion criteria
    • RCTs
    • Studies that compared different policies and procedures regarding umbilical cord management in late preterm infants (34w0d to 36w6d) and term infants (≥37w0d)
  • Study design
    • Two authors independently assessed eligibility of trials and extracted data
    • Certainty of evidence was assessed with GRADE criteria
    • Perinatal outcomes chosen based on clinical relevance and likelihood of influencing practice

RESULTS:

  • 46 studies | 9159 women and their infants
  • Compared to early cord clamping (ECC) <30 seconds, all of the following umbilical cord management strategies improved hematological measures (Hgb and Hct at 24 hours after birth)
    • Delayed cord clamping (DCC) ≥30 seconds (33 studies)
    • Intact-cord milking (1 study)
    • Cut-cord milking (2 studies)
  • Alternative umbilical cord management strategies (delayed clamping and milking) may not have an effect on
    • Survival without neurodisability (authors note that there are limited studies with this finding as an endpoint)
    • Anemia in early infancy
    • Maternal postpartum hemorrhage
  • No differences were found in major neonatal morbidities in studies comparing methods for optimizing placental transfusion
    • DCC vs cut-cord milking (3 studies)
    • Longer delays in clamping (7 studies)
    • Physiologic parameters (3 studies)
  • Strategies that promote increased placental transfusion may be associated with greater phototherapy use
  • Evidence for all outcomes was low or very low certainty

CONCLUSION:

  • Compared to ECC, both DCC and cord milking increases hemoglobin and hematocrit after birth in infants ≥34 weeks’ gestational age
    • Data consistent with Cochrane review
  • Further RCTs are necessary to assess longer term benefits
  • The authors state

Compared to ECC, DCC (at ≥30 seconds) and cord milking led to increased hemoglobin and hematocrit immediately after birth in infants ≥34 weeks’ gestational age

The effects of later clamping or use of cord milking in term and late preterm infants on survival without neurodisability, anemia in early infancy, or maternal PPH (and most other outcomes reported) are uncertain 

Learn More – Primary Sources:

Umbilical Cord Management at Term and Late Preterm Birth: A Meta-analysis

Now You Can Get Mobile-Friendly ObG Clinical Research Summaries with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

RCT Results: Cut vs Intact Umbilical Cord Milking
Umbilical Cord Management at Birth: What is the Better Option for Very Preterm Infants?

Sections

  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • COVID-19

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site